找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問(wèn)微社區(qū)

1234567
返回列表
打印 上一主題 下一主題

Titlebook: Cancer Immunology; Cancer Immunotherapy Nima Rezaei Book 20151st edition Springer-Verlag Berlin Heidelberg 2015 Cancer immunology.Cancer im

[復(fù)制鏈接]
樓主: hierarchy
61#
發(fā)表于 2025-4-1 04:31:31 | 只看該作者
Immunopathology of Head and Neck Tumors and Immunotherapy of Squamous Cell Carcinoma,ce has been induced by cytotoxic T lymphocytes (CTLs), specific immune suppression is associated with tumor malignancy and progression. This contributes to unsatisfactory clinical outcome. In squamous cell carcinoma of the head and neck, the presence, activity, and also suppression of tumor-specific
62#
發(fā)表于 2025-4-1 07:16:33 | 只看該作者
Immunotherapy and Immunosurveillance of Oral Cancers: Perspectives of Plasma Medicine and Mistletoetime, a second tumor, located at the kidney, however remained unaffected. The main difference in treatment being peritumoral vs. systematic application supports the hypothesis of immunosurveillance. The impact of mistletoe extract in direct contact with the tumor tissue might be explained by targete
63#
發(fā)表于 2025-4-1 11:56:23 | 只看該作者
Immunopathology of Bone and Connective Tissue Cancers and Immunotherapy of Sarcomas, of the first forms of immunotherapy for the treatment of sarcoma. With advancements in molecular oncology and the identification of specific sarcoma antigens, direct experimentation has been made possible in a variety of preclinical animal models. Discoveries from the laboratory have led to novel i
64#
發(fā)表于 2025-4-1 16:18:23 | 只看該作者
65#
發(fā)表于 2025-4-1 19:52:33 | 只看該作者
Immunotherapy of Lung Tumors,nly in some countries. The recent campaigns aimed at cessation of smoking have dramatically reduced cardiovascular events in some European countries. However, lung cancer remains an elusive disease with not much improvement in overall survival despite neoadjuvant chemotherapy, making this tumor a di
66#
發(fā)表于 2025-4-1 23:57:44 | 只看該作者
67#
發(fā)表于 2025-4-2 03:42:13 | 只看該作者
68#
發(fā)表于 2025-4-2 08:05:42 | 只看該作者
1234567
返回列表
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-25 13:52
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
邛崃市| 衡阳市| 荆门市| 铅山县| 凉城县| 新营市| 潜山县| 凤凰县| 称多县| 恭城| 永寿县| 观塘区| 峨眉山市| 斗六市| 建昌县| 灵石县| 临夏市| 崇州市| 左权县| 宁海县| 延津县| 柳河县| 从江县| 黑龙江省| 岳普湖县| 修武县| 新丰县| 肇源县| 郁南县| 灌云县| 怀仁县| 桐庐县| 张北县| 泌阳县| 格尔木市| 上虞市| 沛县| 深圳市| 北京市| 宜昌市| 江津市|